Inside Nephrology: A Weekly Review
Nefrologia
Pediatric Nephrology Updates: From SRNS to ADPKD
This episode covers recent advances in pediatric nephrology, including steroid-resistant nephrotic syndrome guidelines, tolvaptan for ADPKD, nutritional management in CKD, updated KDIGO guidelines, and C3 glomerulopathy consensus recommendations.
Accedi o Registrati per ascoltare questo episodio
Bibliografia
1. IPNA clinical practice recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome.
Authors: Trautmann A, Vivarelli M, Samuel S, et al.
Journal: Pediatric nephrology (Berlin, Germany)
PMID: 32382828
DOI: 10.1007/s00467-020-04519-1
2. Tolvaptan for Children and Adolescents with Autosomal Dominant Polycystic Kidney Disease: Randomized Controlled Trial.
Authors: Mekahli D, Guay-Woodford LM, Cadnapaphornchai MA, et al.
Journal: Clinical journal of the American Society of Nephrology : CJASN
PMID: 36719158
DOI: 10.2215/CJN.0000000000000022
3. Nutritional status and the risk of malnutrition in older adults with chronic kidney disease - implications for low protein intake and nutritional care: A critical review endorsed by ERN-ERA and ESPEN.
Authors: Piccoli GB, Cederholm T, Avesani CM, et al.
Journal: Clinical nutrition (Edinburgh, Scotland)
PMID: 36857954
DOI: 10.1016/j.clnu.2023.01.018
4. Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns.
Authors: Levin A, Ahmed SB, Carrero JJ, et al.
Journal: Kidney international
PMID: 38519239
DOI: 10.1016/j.kint.2023.10.016
5. C3 glomerulopathy: consensus report.
Authors: Pickering MC, D'Agati VD, Nester CM, et al.
Journal: Kidney international
PMID: 24172683
DOI: 10.1038/ki.2013.377
Authors: Trautmann A, Vivarelli M, Samuel S, et al.
Journal: Pediatric nephrology (Berlin, Germany)
PMID: 32382828
DOI: 10.1007/s00467-020-04519-1
2. Tolvaptan for Children and Adolescents with Autosomal Dominant Polycystic Kidney Disease: Randomized Controlled Trial.
Authors: Mekahli D, Guay-Woodford LM, Cadnapaphornchai MA, et al.
Journal: Clinical journal of the American Society of Nephrology : CJASN
PMID: 36719158
DOI: 10.2215/CJN.0000000000000022
3. Nutritional status and the risk of malnutrition in older adults with chronic kidney disease - implications for low protein intake and nutritional care: A critical review endorsed by ERN-ERA and ESPEN.
Authors: Piccoli GB, Cederholm T, Avesani CM, et al.
Journal: Clinical nutrition (Edinburgh, Scotland)
PMID: 36857954
DOI: 10.1016/j.clnu.2023.01.018
4. Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns.
Authors: Levin A, Ahmed SB, Carrero JJ, et al.
Journal: Kidney international
PMID: 38519239
DOI: 10.1016/j.kint.2023.10.016
5. C3 glomerulopathy: consensus report.
Authors: Pickering MC, D'Agati VD, Nester CM, et al.
Journal: Kidney international
PMID: 24172683
DOI: 10.1038/ki.2013.377
